Cytoskeleton reassembly in cardiomyocytes infected by Trypanosoma cruzi is triggered by treatment with ergosterol biosynthesis inhibitors

International Journal of Antimicrobial Agents

Volumn 27, Issue 6, 2006, Pages 530-537

  Silva, Dayse T ^a   de Meirelles, Maria de Nazareth S L ^a   Almeida, Danielle ^a   Urbina, Julio A ^b   Pereira, Mirian Claudia S ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

Cardiomyocytes; Cytoskeleton; Ergosterol biosynthesis inhibitors; Trypanosoma cruzi

Indexed keywords

ANTIPARASITIC AGENT; ANTITRYPANOSOMAL AGENT; CYTOSKELETON PROTEIN; ERGOSTEROL; KETOCONAZOLE; POSACONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; DRUG EFFECT; DRUG MECHANISM; HEART MUSCLE CELL; HOST CELL; HUMAN; IMMUNOFLUORESCENCE; MALE; MICROTUBULE; MOUSE; MUSCLE FIBRIL; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; TRYPANOSOMA CRUZI;

ANIMALS; CELLS, CULTURED; CYTOSKELETON; ERGOSTEROL; KETOCONAZOLE; MICE; MYOCYTES, CARDIAC; MYOFIBRILS; TRIAZOLES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 33646765351     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.12.012     Document Type: Article

References (48)

1. Elizari M.V. Chagasic myocardiopathy: historical perspective. Medicina (B Aires) 59 Suppl. 2 (1999) 25-40 [in Spanish]
2. Elizari M.V. Arrhythmias associated with Chagas' heart disease. Card Electrophysiol Rev 6 (2002) 115-119
3. Higuchi Mde L., Benvenuti L.A., Martins Reis M., and Metzger M. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 60 (2003) 96-107
4. Urbina J.A., and Docampo R. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol 19 (2003) 495-501
5. Schmunis G.A. Risk of Chagas disease through transfusions in the Americans. Medicina (B Aires) 59 Suppl. 2 (1999) 125-134 [in Spanish]
6. Angelis M., Cooper J.T., and Freeman R.B. Impact of donor infections on outcome of orthotopic liver transplantation. Liver Transpl 9 (2003) 451-462
7. Kirchhoff L.V., Weiss L.M., Wittner M., and Tanowitz H.B. Parasitic diseases of the heart. Front Biosci 9 (2004) 706-723
8. Centers for Disease Control and Prevention (CDC). Chagas disease after organ transplantation--United States, 2001. MMWR Morb Mortal Wkly Rep 2002;51:210-2.
9. Coura J.R., and de Castro S.L. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 97 (2002) 3-24
10. Filardi L.S., and Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans R Soc Trop Med Hyg 81 (1987) 755-759
11. De Souza E.M., Lansiaux A., Bailly C., et al. Phenyl substitution of furamidine markedly potentiates its anti-parasitic activity against Trypanosoma cruzi and Leishmania amazonensis. Biochem Pharmacol 68 (2004) 593-600
12. Garzoni L.R., Waghabi M.C., Baptista M.M., et al. Antiparasitic activity of risedronate in a murine model of acute Chagas' disease. Int J Antimicrob Agents 23 (2004) 286-290
13. Garzoni L.R., Caldera A., Meirelles M.N., et al. Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi. Int J Antimicrob Agents 23 (2004) 273-285
14. Guedes P.M., Urbina J.A., de Lana M., et al. Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts. Antimicrob Agents Chemother 48 (2004) 4286-4292
15. Santa-Rita R.M., Santos Barbosa H., Meirelles M.N., and de Castro S.L. Effect of the alkyl-lysophospholipids on the proliferation and differentiation of Trypanosoma cruzi. Acta Trop 75 (2000) 219-228
16. Urbina J.A. Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites. Parasitology 114 Suppl. (1997) S91-S99
17. Buckner F., Yokoyama K., Lockman J., et al. A class of sterol 14-demethylase inhibitors as anti-Trypanosoma cruzi agents. Proc Natl Acad Sci USA 100 (2003) 15149-15153
18. Docampo R., and Schmunis G.A. Sterol biosynthesis inhibitors: potential chemotherapeutics against Chagas disease. Parasitol Today 13 (1997) 129-130
19. Isaacson D.M., Tolman E.L., Tobia A.J., et al. Selective inhibition of 14 alpha-desmethyl sterol synthesis in Candida albicans by terconazole, a new triazole antimycotic. J Antimicrob Chemother 21 (1998) 333-343
20. Urbina J.A., Payares G., Contreras L.M., et al. Antiproliferative effects and mechanism of action of posaconazole against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob Agents Chemother 42 (1998) 1771-1777
21. De Castro S.L. The challenge of Chagas' disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi. Acta Trop 53 (1993) 83-98
22. Molina J., Martins-Filho O., Brener Z., Romanha A.J., Loebenberg D., and Urbina J.A. Activities of the triazole derivative SCH56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts. Antimicrob Agents Chemother 44 (2000) 150-155
23. Andrade S.G., Freitas L.A., Peyrol S., Pimentel A.R., and Sadigursky M. Experimental chemotherapy of Trypanosoma cruzi infection: persistence of parasite antigens and positive serology in parasitologically cured mice. Bull World Health Organ 69 (1991) 191-197
24. Barbosa H.S., and Meirelles M.N. Evidence of participation of cytoskeleton of heart muscle cells during the invasion of Trypanosoma cruzi. Cell Struct Funct 20 (1995) 275-284
25. Rosestolato C.T., Dutra J.M., De Souza W., and de Carvalho T.M. Participation of host cell actin filaments during interaction of trypomastigote forms of Trypanosoma cruzi with host cells. Cell Struct Funct 27 (2002) 91-98
26. Tardieux I., Webster P., Ravesloot J., et al. Lysosome recruitment and fusion are early events required for trypanosome invasion of mammalian cells. Cell 71 (1992) 1117-1130
27. Woolsey A.M., and Burleigh B.A. Host cell actin polymerization is required for cellular retention of Trypanosoma cruzi and early association with endosomal/lysosomal compartments. Cell Microbiol 6 (2004) 829-838
28. Low H.P., Paulin J.J., and Keith C.H. Trypanosoma cruzi infection of BSC-1 fibroblast cells causes cytoskeletal disruption and changes in intracellular calcium levels. J Protozool 39 (1992) 463-470
29. Pereira M.C., Costa M., Chagas Filho C., and de Meirelles M.N. Myofibrillar breakdown and cytoskeletal alterations in heart muscle cells during invasion by Trypanosoma cruzi: immunological and ultrastructural study. J Submicrosc Cytol Pathol 25 (1993) 559-569
30. Fernandes A.B., and Mortara R.A. Invasion of MDCK epithelial cells with altered expression of Rho GTPases by Trypanosoma cruzi amastigotes and metacyclic trypomastigotes of strains from the two major phylogenetic lineages. Microbes Infect 6 (2004) 460-467
31. Procopio D.O., Barros H.C., and Mortara R.A. Actin-rich structures formed during the invasion of cultured cells by infective forms of Trypanosoma cruzi. Eur J Cell Biol 78 (1999) 911-924
32. Procópio D.O., da Silva S., Cunningham C.C., and Mortara R.A. Trypanosoma cruzi: effect of protein kinase inhibitors and cytoskeletal protein organization and expression on host cell invasion by amastigotes and metacyclic trypomastigotes. Exp Parasitol 90 (1998) 1-13
33. 2+ mobilization and microfilament rearrangement in host cells. J Cell Biol 129 (1995) 1263-1273
34. Woolsey A.M., Sunwoo L., Petersen C.A., Brachmann S.M., Cantley L.C., and Burleigh B.A. Novel PI 3-kinase-dependent mechanisms of trypanosome invasion and vacuole maturation. J Cell Sci 116 (2003) 3611-3622
35. 2+ signaling in mammalian cells. J Cell Biol 136 (1997) 609-620
36. Melo T.G., Almeida D.S., Meirelles M.N.S.L., and Pereira M.C.S. Trypanosoma cruzi infection disrupts vinculin costameres in cardiomyocytes. Eur J Cell Biol 83 (2004) 531-540
37. Meirelles M.N., de Araujo-Jorge T.C., Miranda C.F., de Souza W., and Barbosa H.S. Interaction of Trypanosoma cruzi with heart muscle cells: ultrastructural and cytochemical analysis of endocytic vacuole formation and effect upon myogenesis in vitro. Eur J Cell Biol 41 (1986) 198-206
38. Meirelles M.N., Souto-Padron T., and De Souza W. Participation of cell surface anionic sites in the interaction between Trypanosoma cruzi and macrophages. J Submicrosc Cytol 16 (1984) 533-545
39. Urbina J.A., Payares G., Molina J., et al. Cure of short- and long-term experimental Chagas' disease using D0870. Science 273 (1996) 969-971
40. Urbina J.A., Payares G., Sanoja C., Lira R., and Romanha A.J. In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease. Int J Antimicrob Agents 21 (2003) 27-38
41. Buckner F.S., Griffin J.H., Wilson A.J., and Van Voorhis W.C. Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors. Antimicrob Agents Chemother 45 (2001) 1210-1215
42. Molina J., Brener Z., Romanha A.J., and Urbina J.A. In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi. J Antimicrob Chemother 46 (2000) 137-140
43. Liendo A., Lazardi K., and Urbina J.A. In-vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi. J Antimicrob Chemother 41 (1998) 197-205
44. Ishihara T., Kakuta H., Moritani H., Ugawa T., and Yanagisawa I. Synthesis and biological evaluation of novel propylamine derivatives as orally active squalene synthase inhibitors. Bioorg Med Chem 12 (2004) 5899-5908
45. Urbina J.A., Concepcion J.L., Caldera A., et al. In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi. Antimicrob Agents Chemother 48 (2004) 2379-2387
46. Lin Z.X., Eshelman J.R., Forry-Schaudies S., Duran S., Lessard J.L., and Holtzer H. Sequential disassembly of myofibrils induced by myristate acetate in cultured myotubes. J Cell Biol 105 (1987) 1365-1376
47. Lin Z.X., Eshleman J., Grund C., et al. Differential response of myofibrillar and cytoskeletal proteins in cells treated with phorbol myristate acetate. J Cell Biol 108 (1989) 1079-1091
48. Lin Z.X., Holtzer S., Schultheiss T., et al. Polygons and adhesion plaques and the disassembly and assembly of myofibrils in cardiac myocytes. J Cell Biol 108 (1989) 2355-2367